Human brain evolution in a dish
Understanding the origin of human brain evolution and the underlying molecular mechanisms is made challenging by the complexity of the brain itself and ethical barriers to the use of human samples. The Kalebic team discusses how human forebrain organoids can be exploited to study human brain evolution and neurodevelopmental pathologies.
Human brain evolution has been linked to an increase in brain size and, in particular, to the expansion of the neocortex, a specialised brain region that controls higher cognitive functions such as conscious decision-making and language. The expansion of the neocortex is the result of an increased production of neuronal cells from neural progenitor cells named basal radial glia (bRG). Impaired proliferation of bRG impacts on neuronal cells and leads to the onset of neurodevelopmental disorders.
Flaminia Kaluthantrige Don and Nereo Kalebic at the HT Neurogenomics Research Centre review current research on cerebral organoids – miniature organ-like 3D structures grown from cultured pluripotent stem cells and recapitulating the key features of human brain – as a tool to investigate human brain development in vitro, thus overcoming the limitations to the access and availability of human brain specimens. The researchers discuss how forebrain organoids have been instrumental to shed light on molecular and cellular features of the bRG, and how deregulation of vital signalling pathways in bRG is involved in the onset of various neurodevelopmental diseases.
The review is published in Frontiers in Cell and Developmental Biology.
The image shows neural progenitor cells (green) lining a ventricle of a day 76 brain organoid. A subpopulation of these progenitors, called basal radial glia (bRG), marked by a bRG marker (magenta), have their proliferating niche further away from the ventricle.
Share:
You could also like:
-
From RNA to proteins: AIRC supports Human Technopole’s new approaches to cancer research
Lorenzo Calviello and his group of the Human Technopole’s Research Centres for Genomics and Computational Biology have been awarded a five-year My First AIRC Grant by Fondazione AIRC per la Ricerca sul Cancro. The grant provides over €99,000 for 2026, for a total of €500,000, to support a project aimed at identifying cancer-specific proteins that could serve as new immunotherapy targets in colorectal cancer.
-
How sortilin senses thyroglobulin along its pathway to thyroid hormone release
Human Technopole researchers have identified the molecular mechanisms by which the membrane receptor sortilin binds thyroglobulin along its pathway to the release of thyroid hormones within the thyroid gland. The results of the research were published in Nature Communications and highlight that sortilin senses thyroglobulin via a short flexible “tag” which appears to be a common motif for the recognition of other partner proteins throughout our body.
-
AI4Life: A European Success for Artificial Intelligence in the Life Sciences
The AI4Life project, co-led by Florian Jug (Computational Biology Research Centre at Human Technopole) and Anna Kreshuk (EMBL), received the highest possible score in the European Commission’s final review, recognising its scientific impact and the quality of its achievements in applying artificial intelligence to biological image analysis.
-
Human Technopole awarded FIS grant for precision immunotherapy research
The Giustacchini Group of the Genomics Research Centre of Human Technopole has been awarded a €1.66 million grant from the Fondo Italiano per la Scienza (FIS 2) to advance precision immunotherapy for haematological malignancies. The three-year project, titled “Tailoring Precision Immunotherapy to Haematological Malignancies”, aims to develop more effective cell-based therapies for blood cancers by integrating molecular, cellular and systems-level analyses.
-
Highlights from the 2nd Conference “Future Trends in Translational Medicine”
Turning scientific discoveries into real-world therapies was the focus of the second international conference “Future Trends in Translational Medicine – From Molecules to Therapies,” held at the Complesso Universitario di San Giovanni a Teduccio in Naples on 30 -31 October 2025.